Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3776804014 | Product containing halobetasol and tazarotene in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3779171015 | Halobetasol- and tazarotene-containing product in cutaneous dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4648261000052119 | läkemedel som innehåller halobetasol och tazaroten, kutan läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing halobetasol and tazarotene in cutaneous dose form (medicinal product form) | Is a | Product containing halobetasol and tazarotene (medicinal product) | true | Inferred relationship | Some | ||
| Product containing halobetasol and tazarotene in cutaneous dose form (medicinal product form) | Is a | Tazarotene-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
| Product containing halobetasol and tazarotene in cutaneous dose form (medicinal product form) | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Some | ||
| Product containing halobetasol and tazarotene in cutaneous dose form (medicinal product form) | Is a | Product containing halobetasol in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing halobetasol and tazarotene in cutaneous dose form (medicinal product form) | Has active ingredient | Tazarotene (substance) | true | Inferred relationship | Some | 1 | |
| Product containing halobetasol and tazarotene in cutaneous dose form (medicinal product form) | Has active ingredient | Halobetasol | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only halobetasol and tazarotene in cutaneous dose form (medicinal product form) | Is a | True | Product containing halobetasol and tazarotene in cutaneous dose form (medicinal product form) | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR